Search Results 31-40 of 31344 for Relapse

  1. Recurrent breast cancer - Symptoms and causes - Mayo Clinic

    Learn about symptoms that alert doctors to a breast cancer recurrence and strategies for treating cancer that comes back after initial treatment.

  2. Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy - Mayo Clinic

    Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy.

  3. Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia - Mayo Clinic

    About this study. This phase II trial studies how well sapanisertib works in treating patients with acute lymphoblastic leukemia that has returned after a ...

  4. Drinking alcohol: Is it safe after hepatitis C cure? - Mayo Clinic

    Relapses usually occur in the first few months after blood testing to confirm that the virus is no longer detectable. Sometimes, however, a relapse becomes ...

  5. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia - Mayo Clinic

    A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · Overview.

  6. Mononucleosis: Can it recur? - Mayo Clinic

    The disease often goes away in 2 to 4 weeks after causing symptoms such as fever and fatigue. Mono is caused by a viral infection. Most cases of mononucleosis ...

  7. Alcohol use disorder - Symptoms and causes - Mayo Clinic

    Alcohol use disorder relapse factors: A systematic review. Psychiatry Research. 2019; doi:10.1016/j.psychres.2019.05.038. Thiamin deficiency. Merck Manual ...

  8. A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

    The purpose of this study is to determine the maximum tolerated dose of this drug (MEDI-551) in subjects with advanced B-cell malignancies. Expansion to occur ...

  9. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

    Clinical Trials · Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) · More about research at ...

  10. Determining the best treatment course for patients with multiple myeloma - Mayo Clinic

    Relapse should be expected with multiple myeloma, with each treatment regimen administered offering the patient roughly two to three years of disease control.